GRI Bio (GRI) News Today → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free GRI Stock Alerts 0.41 0.00 (-0.39%) (As of 02:15 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 9:05 AM | globenewswire.comGRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company ShowcaseMay 13 at 11:32 AM | msn.comGRI Stock Earnings: GRI Bio Reported Results for Q1 2024May 13 at 8:00 AM | globenewswire.comGRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 13 at 7:14 AM | americanbankingnews.comGRI Bio (NASDAQ:GRI) Releases Earnings ResultsMay 2, 2024 | msn.comBabraham-based Harness Therapeutics appoints Meenu Chhabra Karson as board chairApril 29, 2024 | globenewswire.comGRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityApril 25, 2024 | globenewswire.comGRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarApril 18, 2024 | finanznachrichten.deGRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentApril 16, 2024 | globenewswire.comGRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentApril 8, 2024 | globenewswire.comGRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceApril 1, 2024 | globenewswire.comGRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comGRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 14, 2024 | finanznachrichten.deGRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 14, 2024 | finance.yahoo.comGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 14, 2024 | globenewswire.comGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 4, 2024 | finanznachrichten.deGRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomMarch 4, 2024 | globenewswire.comGRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomFebruary 23, 2024 | benzinga.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 3, 2024 | msn.comGRI Bio Launches Major Securities Public OfferingFebruary 2, 2024 | msn.comGRI Bio prices 5M shares at $1.10 in public offeringFebruary 2, 2024 | marketwatch.comGRI Bio Shares Drop After Stock Offering Prices Below Thursday's CloseFebruary 2, 2024 | markets.businessinsider.comGRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock DownFebruary 2, 2024 | investorplace.comWhy Is GRI Bio (GRI) Stock Down 21% Today?February 1, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 10:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 10:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 10:02 AM with a stated reason of "LULD pause." Trading set to resume at 10:02 AM. February 1, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 10:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 10:02 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "GRI" at 07:01 PM with a stated reason of "News pending."January 26, 2024 | finanznachrichten.deGRI Bio, Inc.: GRI Bio Announces Reverse Stock SplitJanuary 26, 2024 | msn.comGRI Bio's board OKs 1-for-7 reverse stock splitJanuary 26, 2024 | finance.yahoo.comGRI Bio Announces Reverse Stock SplitJanuary 9, 2024 | finance.yahoo.comGRI Bio, Inc. (GRI) Stock Historical Prices & Data - Yahoo FinanceJanuary 3, 2024 | chicago.suntimes.comWeed dispensary plan scrapped at old Rainforest Cafe in River NorthDecember 21, 2023 | msn.comGRI Bio files to sell common stock, warrantsNovember 27, 2023 | markets.businessinsider.comGRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%November 27, 2023 | msn.comGRI Bio stock slides 9% amid FDA clearance for testing of IPF drugNovember 24, 2023 | morningstar.comGRI Bio Inc GRINovember 15, 2023 | finanznachrichten.deGRI Bio, Inc.: GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 15, 2023 | msn.comGRI Bio reports Q3 resultsNovember 6, 2023 | msn.comLawsuit alleges plan to open a marijuana store in former Rainforest Cafe is illegalOctober 31, 2023 | chicago.suntimes.comPot shop company files suit to blunt planned dispensary at former Rainforest Cafe, limit proximity of minority-owned storesOctober 17, 2023 | markets.businessinsider.comGRI Bio Partners With NIHR Respiratory TRC To Advance NKT Regulation Technology - Quick FactsOctober 11, 2023 | finance.yahoo.comGRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO ConferenceSeptember 29, 2023 | finanznachrichten.deGRI Bio, Inc.: September Is Pulmonary Fibrosis Awareness Month: Here's What One Company Is Doing To Develop A Treatment For This Deadly DiseaseSeptember 18, 2023 | benzinga.comThinking about buying stock in SeqLL, GRI Bio, Earlyworks Co, TradeUP Acquisition, or Safety Shot?September 15, 2023 | benzinga.comDisease With Market Estimated At $3.9 Billion Lacks Cure – Will This Company Be The First To Find One?September 8, 2023 | msn.comElon Musk blocked Ukrainian attack on Russia's Black Sea fleet, says new biographySeptember 1, 2023 | finance.yahoo.comIPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis - Could GRI-0621 Be The Solution?August 29, 2023 | finance.yahoo.comGRI Bio Engages B2i Digital to Deploy Cutting-Edge Engagement Campaign Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely! Learn how this American company is leading the lithium-ion revolution GRI Media Mentions By Week GRI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRI News Sentiment▼0.760.57▲Average Medical News Sentiment GRI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRI Articles This Week▼81▲GRI Articles Average Week Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LSDI News PBLA News BDRX News NBSE News INM News ATNF News NLSP News SBFM News PRFX News EVLO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRI) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
